Table 1.
Vaccine against | Type | Disease type | Reference |
---|---|---|---|
Rabies | Human diploid cell vaccine | PV—new onset | Yalçin B, J Dermatol, 2007 |
Influenza |
N/a N/a |
PV—exacerbation PV—new onset |
De Simone C, Clin Exp Dermatol, 2008 Mignogna M, Int J Dermatol, 2000 |
Hepatitis B | Recombinant (Engerix‐B) | PV—new onset | Berkun Y, Autoimmunity, 2005 |
Typhoid | Typhim Vi | PV—new onset | Bellaney G, Clin Exp Dermatol, 1996 |
Tetanus | N/a | PF—exacerbation | Korang K, Acta Derm Venereol, 2002 |
Anthrax | Anthrax vaccine absorbed (AVA) | PV—new onset | Muellenhoff M, J Am Acad Dermatol, 2004 |
Sars‐CoV2 | Modified mRNA | PV—new onset | Solimani F, J Eur Acad Dermatol Venereol, 2021 |
N/a, not available; PV, Pemphigus vulgaris; PF, Pemphigus foliaceus.